Doctors’ Knowledge and Practices Regarding Chronic Kidney Disease at a Tertiary Care Hospital

Authors

  • Mahvesh Mahmud Ziauddin University Hospital, Karachi http://orcid.org/0000-0002-2036-2151
  • Nida Hussain Ziauddin University Hospital, Karachi
  • Amal Kamal Ziauddin University Hospital, Karachi
  • Zarak Iqbal Samoo Ziauddin University Hospital, Karachi
  • Wahaaj Ali Khan

DOI:

https://doi.org/10.3823/1959

Keywords:

Chronic Kidney Disease, Doctors, Knowledge, Practices, practice guidelines

Abstract

Background: The complications of chronic kidney disease (CKD) significantly contribute to morbidity and mortality, therefore clinical practice guidelines have been developed to facilitate early detection and treatment. However, given the high prevalence of CKD, many patients with early CKD are seen by non-nephrologists, who need to be aware of CKD complications, screening methods and treatments goals in order to initiate timely therapy and referral.

Methods: This was a cross-sectional study conducted at three campuses of the Ziauddin University Hospital, Karachi, Pakistan in 2016. A questionnaire based survey was conducted to assess the knowledge and practices of doctors from various specialties regarding CKD.

Results: We performed a questionnaire based survey to assess knowledge and practice patterns in CKD care among 156 doctors. There were 63 male and 50 female respondents. There were 24 attending doctors, 73 post-graduate trainees and 25 house-officers. Our data showed that although CKD risk factors are generally recognized, there is a paucity of knowledge regarding CKD management guidelines and staging of CKD. There is an awareness regarding timely referral to nephrology, but many would still not refer at the appropriate stage. Many also do not use standard equations to calculate Glomerular Filtration rate (GFR) and Creatinine Clearance). Most do screen for diabetic nephropathy, know about ACE-I/ARBs and provide dietary counseling to CKD patients. The majority do not read medical journals to keep their knowledge up-to-date. Junior doctors (post-graduate trainees and house-officers) fared better than attending doctors in the knowledge and practice parameters.

Conclusion: Our survey shows that there is a requirement for continuing education and awareness among doctors regarding CKD  and its management guidelines, as well as timely referral to a nephrologist. Facing a growing CKD incidence, doctors can have an impact on preventing its progression and associated complications with increased familiarity of local guidelines. 

Author Biographies

Mahvesh Mahmud, Ziauddin University Hospital, Karachi

Medicine/Nephrology, Assistant Professor

Nida Hussain, Ziauddin University Hospital, Karachi

Medical Student (final year)

References

References:

McCullough, B., et al. (2010) Sustainable community-based CKD screening methods employed by the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases, 57, S4-S8

Khalil, A., Frazier, K., Lennie, T. & Saway, P. (2011). Depressive symptoms and dietary adherence in patients with end-stage renal disease. Journal of Renal Care, 37, 30-39

Lozano R., et al. (2013).Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-2128

Saleem Jessani, Rasool Bux and Tazeen H Jafar; Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. BMC Nephrology 2014, 15:90

Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007;50(2):169–180. [PubMed: 17660017]

El Nahas, A. & MMedSci, A. (2005) Chronic Kidney Disease: the global challenge. Lancet, 365, 331-340

A. Khalil & M. Abdalrahim. Knowledge, attitudes, and practices towards prevention and early detection of chronic kidney disease. International Nursing Review 2014

Ibrahim, M. & Damasceno, A. (2012) Hypertension in developing countries. Lancet, 382, 611-619

Wetterhall SF, Olson DR, DeStefano F, et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care. 1992; 15: 960-7

Coresh J, Astor B, Sarnak MJ. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004; 13: 73–81.

Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050–65.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–305.

Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285–95.

Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar MH, et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertension 2003; 21:905-12

Shera AS, Rafique G, Khawaja IA, Ara J, Baqai S, King H. Pakistan national diabetes survey: prevalence of glucose intolerance and associated factors in Shikarpur, Sindh Province, Diabetes Med 1995; 12 – 1116-21

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351(13):1296–1305. [PubMed:15385656]

Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, Messer KL, Levey AS, Powe NR. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med 2008; 168(20):2268–2275. [PubMed: 19001205]

Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radhakrishnan J. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES)1999 to 2000. Am J Kidney Dis 2004;44(2):185–197. [PubMed: 15264176]

Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16(1):180–188. [PubMed: 15563563]

Paul A. James, MD1; Suzanne Oparil, MD2; Barry L. Carter, PharmD1; William C. Cushman, MD3; Cheryl Dennison-Himmelfarb, RN, ANP, PhD4; Joel Handler, MD5; Daniel T. Lackland, DrPH6; Michael L. LeFevre, MD, MSPH7; Thomas D. MacKenzie, MD, MSPH8; Olugbenga Ogedegbe, MD, MPH, MS9; Sidney C. Smith Jr, MD10; Laura P. Svetkey, MD, MHS11; Sandra J. Taler, MD12; Raymond R. Townsend, MD13; Jackson T. Wright Jr, MD, PhD14; Andrew S. Narva, MD15; Eduardo Ortiz, MD, MPH. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) . JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427.

Standards of Medical Care in Diabetes Care. Position Statement of the American Diabetes Association. Diabetes Care, Volume 32, Supplement 1, Jan 2009

Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72(3):247–259. [PubMed: 17568785]

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. Am J Nephrol 2007;27(1):108–112. [PubMed: 17308371]

Chin HJ, Ahn JM, Na KY, Chae DW, Lee TW, Heo NJ, Kim S. The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression. Nephrol Dial Transplant. 2009 in press.

Bakris G, Collins AJ. Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data Report. Am J Kidney Dis 2008; 51(4):S1–S2. [PubMed: 18359402]

Vassalotti JA, Li S, Chen SC, Collins AJ. Screening populations at increased risk of CKD: The Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 2009;53(3 Suppl3): S107–S114. [PubMed: 19231754]

Lin CL, Chuang FR, Wu CF, Yang CT. Early referral as an independent predictor of clinical outcome in end-stage renal disease on hemodialysis and continuous ambulatory peritoneal dialysis. Renal Failure 2004; 26 (0886-022; 5):531–537. [PubMed: 15526911]

Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137(6):479–486. [PubMed:12230348]

Roderick P, Jones C, Drey N, Blakeley S, Webster P, Goddard J, Garland S, Bourton L, Mason J, Tomson C. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant 2002;17(7):1252–1259. [PubMed: 12105249]

Jungers P, Massy ZA, Nguyen-Khoa T, Choukroun G, Robino C, Fakhouri F, Touam M, Nguyen AT, Grunfeld JP. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001;16(12):2357–2364. [PubMed:11733627]

Tamizuddin S, Ahmed W. Knowledge, attitude and practices regarding chronic kidney disease and estimated GFR in a tertiary care hospital in Pakistan. JPMA May 2010

Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis 2006; 48: 192-204

Goransson LG, Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Int Med 2001; 250: 154-9

Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Inter Med 2002; 137: 479-86

Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med 2007; 120: 1063-70

Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: Burden of disease and management issues. Kidney International Suppl. 2003; 83: S 115-8. [PubMed]

Muhammad Anees, Asim Mumtaz, Saleem Uz Zaman Adhmi, Muhammad Ibrahim. Knowledge, attitude and practices (KAP) of chronic kidney disease among medical officers of teaching hospitals of Lahore. Annals Vol 20, Issue 1, Jan Mar 2014

S. Yaqub, W. Kashif, M. Q. Raza, H. Aaqil, A. Shahab, M. A. Chaudhary, and S. A. Hussain. General practitioners’ knowledge and approach to chronic kidney disease in Karachi, Pakistan. Indian J Nephrol. 2013 May-Jun; 23(3): 184–190

Jafar TH. The growing burden of chronic kidney disease in Pakistan. N Engl J Med. 2006; 354:995-7.

The KAP survey model (knowledge, attitude and practices), SPRING, https://www.spring-nutrition.org/publications/tool-summaries/kap-survey-model-knowledge-attitudes-and-practices

Lesley A. Inker, Brad C. Astor, Chester H. Fox, Tamara Isakova, James P. Lash, Carmen A. Peralta, Manjula Kurella Tamura, Harold I. Feldman, KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. AJKD May 2014. Volume 63, Issue 5, Pages 713–735

Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: An upstate New York Practice-based Research Network (UNYNET) stud. J Am Board Family Medicine. 2006; 19: 54-61. [PubMed]

Jafar TH, Scmid CH, Levey AS. Serum creatinine as a marker of kidney function in South Asians: A study of reduced GFR in adults in Pakistan. J Am Soc Nephrol 2005; 16: 1413-9

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39: S1–266.

Agaba E, Agaba P, Dankyau M, Akanbi M, Daniyam C, Okeke E, et al. Specialist physician knowledge of chronic kidney disease: a comparison of internists and family physicians in West Africa. Afr J Prm Health Care Fam Med. 2012;4(1):7.

Simeon‑Pierre Choukem, Pennghan K. Nchifor, Marie‑Patrice Halle, Daniel N. Nebongo, Yannick Mboue‑Djieka, François F. Kaze and Gotlieb L. Monekosso. Knowledge of physicians on chronic kidney disease and their attitudes towards referral, in two cities of Cameroon: a cross-sectional study. BMC Res Notes (2016) 9:29 DOI 10.1186/s13104-016-1845-5

Noble E, Johnson DW, Gray N, Hollett P, Hawley CM, Campbell SB, et al. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant. 2008;23(12):3845–50. 17.

Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, et al. Impact of estimated GFR reporting on patients, clini cians, and health-care systems: a systematic review. Am J Kidney Dis. 2011;57(4):592–601

Lenz O, Fornoni A. Chronic kidney disease care delivered by US family medicine and internal medicine trainees: Results from an online survey. BMC Med. 2006; 4:30.

KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Disease. 2002; 39: S1-266. [PubMed]

Halle MP, Kengne AP, Ashuntantang G. Referral of patients with kidney impairment for specialist care in a developing country of sub-Saharan Africa. Ren Fail. 2009;31(5):341–8.

Winkelmayer WC, Owen WF Jr, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14(2):486–92

Peña J, Logroño J, Pernaute R, Laviades C, Virto R, de Vincente Vera C. Late nephrology referral influences on morbidity and mortality of hemodialy sis patients. A provincial study. Nefrologia. 2006;26(1):84–97.

Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant. 2004;19:1808-14

Bolton WK: Renal physicians association clinical practice guideline: appropriate patient preparation for renal replacement therapy: guideline number 3. J Am Soc Nephrol 2003, 14:1406-1410

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345; 861-9

Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Aniotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73-87.

Bloom JM: Benazepril for advanced chronic renal insufficiency. N Engl J Med 2006, 354:1530-1531

Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal Insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trail. Ann Intern Med 2001,134:629-636

KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007; 49:S12-154

Baker R: Is it time to review the idea of compliance with guidelines? Br J Gen Pract 2001, 51:7

Downloads

Published

2016-05-30

Issue

Section

Nephrology